Abstract PS3-09-26: Real-world clinical characteristics, treatment patterns and outcomes among UK and French patients with early-stage, estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer treated with neoadjuvant chemotherapy
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: P. S. Hall, E. Sawyer, J. Frenel, K. Desai, K. M. Hirshfield, G. Gooud, D. Ntais, A. Jamotte, C. Perkins, A. Babonneau, E. Kitetere, M. Vallet, M. Riaz, J. Timbres, L. Haroun, L. Cirneanu, R. Hermans, V. Saglimbene, K. Dushkin, A. Ajmal, S. Oikonomou, A. Vladimirova, J. Earla, F. Bocquet, P. Cottu
Institutions: Cancer Research UK, Edinburgh Cancer Research, Institute of Genetics and Cancer, University of Edinburgh, King's College London, Institut de Cancérologie de l'Ouest, Merck & Co., Inc., Rahway, NJ, USA (United States), MSD (Switzerland), MSD (France), Leeds Teaching Hospitals NHS Trust, Institut Curie, IQVIA (United Kingdom), Université Paris Cité
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129536000
Cites:
Cited by:
Related to: